Stocks
Adaptive Biotechnologies (ADPT) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 617.3% | 230.5% | 867.1% | 1 142% | 2 073% | ||||
| Changes by years, y/y, % | -14pp | -387pp | +637pp | -867pp | +13.0% | ||||
Adaptive Biotechnologies. R&D/CAPEX, %
Adaptive Biotechnologies. R&D/CAPEX, changes, pp
Adaptive Biotechnologies (ADPT) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| R&D/CAPEX, % | 1 832% | 2 002% | 1 330% | 7 024% | 2 073% | |||
| Changes by years, y/y, % | -1 228pp | +604pp | +887pp | +458pp | +5 997pp | |||
| Changes by quarters, q/q, % | -1 027pp | +169pp | -672pp | +5 694pp | ||||
